09 January 2024
09 January 2024
In the trial, mazdutide’s safety profile was consistent with that observed in previous studies.
The CureVac and GSK Covid-19 collaboration was first announced in February 2021, with regulatory discussions already in motion.
The results have enabled the drug to progress to a Phase III trial.
The layoffs and scaling back of R&D activities will extend the CAR-NK cell therapy company’s cash runway into Q1 2025.
QuantHealth’s artificial intelligence (AI) platform aims to predict clinical trials’ efficacy and safety to optimise trial design.
The company is carrying out the trial in partnership with Ono Pharmaceutical.
Launched in 2021, the Trust 2 trial studied more than 5,000 lesions in follow-up examinations.
The Phase III ASC4FIRST trial demonstrated improved molecular response rates compared to standard-of-care treatments.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
